Researcher's gloved hand beside neonatal pulse oximeter, tiny sensor wrapped around an infant foot no larger than a thumb
Level IV NICU · IRB Certified · 14 Years Active

Every Trial Begins
With One Question.

Cradle is a neonatal research center where specialists design clinical trials for infants born at the edge of viability — weighing less than a bag of flour. We carry the IRB infrastructure, the longitudinal data, and the Level IV NICU access. You bring the science.

2,400+Enrolled patients
23–40wkGestational range
18-moFollow-up data
Cohort Profile

"What gestational age range
does your cohort cover?"

Our cohort spans 23 to 40 weeks gestational age, with particular depth in the 24–28 week range — the critical window where most intervention trials are designed. Every patient is enrolled with longitudinal consent through 18 months corrected age.

Gestational Age Distribution

23 – 40 weeks

23–24 wk
13%
Periviable312
25–28 wk
37%
Extreme preterm891
29–32 wk
27%
Very preterm648
33–36 wk
18%
Late preterm432
37–40 wk
5%
Term NICU117

Total enrolled · Q4 2025

2,400

Median Birth Weight

847g

Range: 385g – 2,100g. 34% of cohort born under 500g.

Sub-500g: 34% of cohort

Longitudinal Follow-up

18months

Corrected age. Neurodevelopmental, pulmonary, and growth outcomes available.

87% retention rate

Primary Diagnoses

Comorbidity Profile

Multi-diagnosis patients included in all categories

🫁

Respiratory

  • BPD (38%)
  • RDS (61%)
  • Apnea (29%)
❤️

Cardiac

  • PDA (44%)
  • CHD (12%)
  • Arrhythmia (7%)
🧠

Neurological

  • IVH (23%)
  • HIE (11%)
  • NEC (8%)
⚖️

Nutritional

  • IUGR (31%)
  • TPN dep. (56%)
  • FGR (19%)
Operations & Infrastructure

Questions researchers actually ask
before they sign the CTA.

We answer every operational question before asking for anything in return. Because the best research partnerships start with complete information.

Our full-board review completes in 14 calendar days for industry-sponsored trials. Expedited review for minimal-risk amendments averages 5 business days.

Full Board Review

14 days

Industry-sponsored

Expedited Review

5 days

Minimal-risk amendments

Protocol Amendments

48 hrs

Emergency safety changes

87% of our cohort completes the 18-month corrected age follow-up. Data includes Bayley-4 neurodevelopmental scores, pulmonary function, anthropometric growth, and re-hospitalization records.

Bayley-4 ScoresPulmonary FunctionGrowth AnthropometricsRe-hospitalizationMRI Brain (6-mo)Parent-Reported QoL

All data de-identified per HIPAA Safe Harbor. Raw datasets available under executed DUA.

Our Level IV NICU operates 48 private isolette bays with integrated monitoring. Research-dedicated equipment includes high-frequency oscillatory ventilators, amplitude-integrated EEG, and near-infrared spectroscopy — all validated for sub-1kg patients.

HFOV Ventilators

8 units

Draeger VN500

aEEG Monitors

6 units

natus Olympic

NIRS Systems

4 units

Masimo O3

Isolette Bays

48 beds

Private, research-ready

Pharmacokinetic Lab

On-site

Micro-sampling

Biobank

-80°C

12,000 specimens

Yes. Our biorepository holds 12,000+ specimens from 1,800 patients: cord blood, serial plasma, urine, tracheal aspirates, and stool microbiome samples. Minimum volume: 50µL per aliquot.

Cord Blood (CBCs, metabolomics)
1,820 spec.1,820 pts
Serial Plasma (DOL 1, 7, 28)
5,460 spec.1,820 pts
Urine (metabolomic)
2,100 spec.1,050 pts
Tracheal Aspirates
890 spec.445 pts
Stool Microbiome
1,750 spec.875 pts

We execute CDAs within 5 business days, CTAs within 30 days using our pre-negotiated template library. We support FFS, milestone-based, and grant-funded models. No IP restrictions on investigator-initiated trials.

CDA · 5 daysCTA · 30 daysBudget NegotiationIND SupportSponsor-InvestigatorGrant Co-InvestigatorFDA Pre-IND MeetingsNDA Submissions
Published Outcomes

"Can we access longitudinal
follow-up data at 18 months?"

Every trial we run publishes. Below are outcomes from our most recent partnerships — available in full via our capabilities deck.

47+

Published Trials

Peer-reviewed outcomes since 2011

2,400+

Patients Enrolled

Across all active and completed trials

87%

Follow-up Retention

18-month corrected age completion

14 days

IRB Turnaround

Full-board review, industry-sponsored

Selected Publications

RespiratoryNEJM · 2024

Surfactant Replacement in Periviable Neonates: A Phase III Multicenter Trial

Reduced BPD incidence by 31% in 23–25wk cohort

View abstract
CardiacPediatrics · 2023

Prophylactic Indomethacin vs. Expectant Management for PDA Closure

NNT of 4 for surgical ligation avoidance

View abstract
NeurologicalJ Perinatology · 2023

Amplitude-Integrated EEG Prediction of Neurodevelopmental Outcomes at 18 Months

AUC 0.88 for adverse neurodevelopment

View abstract

Research Partners & Sponsor Networks

Children's NationalNICHD NetworkPfizer Rare DiseaseAbbott NutritionVermont Oxford NetworkNIH NHLBI
Currently accepting 2026 trial partnerships

The question that changes
a life weighs less than a gram.

Every trial we run started with one conversation. Our clinical research coordinators are available for a 30-minute pre-consultation — no commitment, no paperwork, no IRB submission required to begin.

IRB Certified

FDA-registered, AAHRPP accredited

Level IV NICU

48 beds, private isolette bays

47 Published Trials

Since 2011, all outcomes available

Research Partnership Form

Step 1 of 3 — Your Role

LIVE
1
2
3

What is your role?

This helps us connect you with the right research coordinator and tailor our capabilities overview.

Download Capabilities Deck

Published results · NICU specs · Investigator bios

Start a Research Conversation